Active Ingredient: ERYTHROMYCIN ESTOLATE; SULFISOXAZOLE ACETYL
Proprietary Name: ILOSONE SULFA
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: EQ 125MG BASE/5ML;EQ 600MG BASE/5ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N050599
Product Number: 001
Approval Date: Sep 29, 1989
Applicant Holder Full Name: ELI LILLY AND CO
Marketing Status:
Discontinued
Patent and Exclusivity Information